Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
- cell therapy
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27362
IPSCIO Record ID: 26784
MULTIKINE(R) is manufactured using proprietary cell culture technologies, is a combination, or 'cocktail', of natural human interleukin-2 ('IL-2') and certain lymphokines and cytokines. MULTIKINE is being tested to determine if it is effective in improving the immune response of cancer patients.
IPSCIO Record ID: 328902
IRX-2 is an allogeneic, reproducible, primary, cell-derived biologic with multiple active cytokine components that act on various parts of the immune system, to activate the entire tumor microenvironment. IRX-2 contains multiple human cytokines that promote or enhance an immune response. IRX-2 is administered as a subcutaneous injection around lymph node beds.
IPSCIO Record ID: 26159
IPSCIO Record ID: 211947
The Licensor PEG Patent Rights means those patents and patent applications directed to the conjugation of interleukin-2 to a water soluble polymer selected from polyethylene glycol homopolymers or polyoxyethylated polyols.
The Licensed Licensee IL-2 Product means any product, including hybrids, conjugates and formulations, containing, by molecular combination or admixture, Roche IL-2 as the only interleukin-2 ingredient, the manufacture, use or sale thereof.
The Licensed Licensee PEG IL-2 Product means any product, including hybrids, conjugates and formulations, containing, by molecular combination or admixture, licensee IL-2 as the only interleukin-2 ingredient, the manufacture, use or sale thereof.